Ascletis Pharmaceuticals Co., Ltd.
Clinical trials sponsored by Ascletis Pharmaceuticals Co., Ltd., explained in plain language.
-
New pill shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-stage trial tested a new oral drug called ASC61 in 18 adults with advanced solid tumors that had stopped responding to standard treatments or had no standard options. The goal was to check the drug's safety, find the right dose, and see if it could shrink tumors. ASC61…
Phase: PHASE1 • Sponsor: Ascletis Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New acne pill passes Long-Term safety check in phase 3 trial
Symptom relief CompletedThis study looked at the long-term safety of a daily pill called ASC40 (Denifanstat) for people with moderate to severe acne. About 240 people who had already finished a 12-week study took the pill for up to 40 weeks. Researchers tracked side effects and checked blood tests to se…
Phase: PHASE3 • Sponsor: Ascletis Pharmaceuticals Co., Ltd. • Aim: Symptom relief
Last updated May 01, 2026 15:59 UTC